Glycogen synthase kinase 3β inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia
- 13 May 2004
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 188 (2) , 378-386
- https://doi.org/10.1016/j.expneurol.2004.04.004
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Overexpression of HSP72 after Induction of Experimental Stroke Protects Neurons from Ischemic DamageJournal of Cerebral Blood Flow & Metabolism, 2001
- Targeting Expression of hsp70i to Discrete Neuronal Populations Using the Lmo-1 Promoter: Assessment of the Neuroprotective Effects of hsp70i In vivo and In vitroJournal of Cerebral Blood Flow & Metabolism, 2001
- Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsyAnnals of Neurology, 1998
- BCL-2 FAMILY: Regulators of Cell DeathAnnual Review of Immunology, 1998
- Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenesNeuroReport, 1997
- Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cellsCurrent Biology, 1994
- Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filamentsFEBS Letters, 1993
- Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tauFEBS Letters, 1992
- Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinaseNeuroscience Letters, 1992
- Glycogen Synthase from Rabbit Skeletal MuscleEuropean Journal of Biochemistry, 1980